Pivotal Research Downgrades USANA Health Sciences Inc. (USNA) to Hold

Pivotal Research downgraded USANA Health Sciences Inc. (NYSE: USNA) from Buy to Hold with a price target of $135.00 (from $125.00). The change is tied to valuation.

Analyst Timothy S. Ramey said, "While we have increased our target price to $135 per share, up from $125 previously, we are reducing our rating to HOLD on valuation. The shares have been on a tear, up 27% YTD. We don’t regard the shares as expensive, particularly, except as they relate to peers Herbalife and Nu Skin."

For an analyst ratings summary and ratings history on USANA Health Sciences Inc. click here. For more ratings news on USANA Health Sciences Inc. click here.

Shares of USANA Health Sciences Inc. closed at $128.29 yesterday.

You May Also Be Interested In

• Morgan Stanley Downgrades XP Inc. (XP) to Equalweight
• KeyBanc Downgrades Sunnova (NOVA) to Sector Weight
• JPMorgan Upgrades Assai Atacadista (ASAI) to Overweight